RUDN chemists discover previously unknown derivatives of chitin

NewsGuard 100/100 Score

Chemists from RUDN University discovered previously unknown derivatives of chitin, a biopolymer that forms the exoskeletons of insects and carapaces of crayfish and other arthropods. The new compounds and their nanoparticles have antibacterial properties and are able to catalyze chemical reactions. The results of the study were published in the International Journal of Biological Macromolecules.

Chitin is the second most widely spread biopolymer on Earth. It is used as a basis for many medicinal drugs and surgical materials, such as burn ointments and gels to promote wound healing. However, chitin and its derivatives are still not fully integrated into medicine. They are not soluble in water or most organic solvents, which makes it difficult to obtain new compounds from them. A team from RUDN University suggested a simple and universal method to synthesize water-soluble chitin derivatives.

In their experiment, the chemists used chitin powder from king crab shells. It was treated with a nitrogen-containing substance at room temperature to obtain chitin derivatives with attached azide groups (three nitrogen atoms). At this stage, the team synthesized three derivatives with azide groups attached to 18%, 42%, and 65% or polymer units. At the second stage, more complex derivatives were constructed from different fragments: an azide group, chitin remains, and nicotinic acid ether. Reactions of this kind are usually carried out in an anaerobic atmosphere, but the team decided to simplify the process and to conduct the experiment under normal conditions. The reagents were subject to ultrasound for 15 minutes. As a result, the team obtained 6 new compounds with different azide group composition and various ethers of nicotinic acid.

The new substances contained groups of atoms with a positive charge that could hypothetically interfere with the work of negatively charged elements in bacterial cell walls. The team tested this theory on two microorganisms: S.aureus and E.coli. In the test, the chemists compared the effects of six new polymers and two antibiotics, ampicillin and gentamicin. The efficiency of each substance was assessed by the diameter of the area around it in which the bacteria died. Most chitin derivatives and their nanoparticles showed better results than the antibiotics, with the zone around one of them being 14.9 mm wider than around ampicillin, when tested on S.aureus. In the case of E.coli, one type of nanoparticles had a 17 mm wider zone around it than gentamicin.

We managed to add previously unknown polymers to the group of water-soluble chitin derivatives. The new substances are non-toxic, show increased antibacterial activity, and can be used as catalysts in organic synthesis. We continue to study the properties of the new compounds. Right now, our group is researching their ability to treat bacterial infections in lab animals."

Andreii Kritchenkov, PhD, Assistant Researcher, Department of Inorganic Chemistry, RUDN University

Source:
Journal reference:

Kritchenkov, A.S., et al. (2020) New water-soluble derivatives of chitin and their based nanoparticles: Antibacterial and catalytic activity. International Journal of Biological Macromolecules. doi.org/10.1016/j.ijbiomac.2020.09.123.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Developing mRNA lipid nanoparticles for treating oral squamous cell carcinoma